UK markets close in 8 hours 15 minutes

Enlivex Therapeutics Ltd. (1BT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.4400-0.0400 (-2.70%)
As of 08:02AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
18,159
19,012
18,693
12,881
6,086
Selling general and administrative
7,440
5,233
6,702
6,240
3,602
Total operating expenses
25,766
25,151
25,797
19,288
9,785
Operating income or loss
-25,766
-25,151
-25,797
-19,288
-9,785
Total other income/expenses net
-2,633
-5,468
-6,084
5,028
-2,258
Income before tax
-28,607
-29,068
-31,060
-14,468
-11,824
Income from continuing operations
-28,607
-29,068
-31,060
-14,468
-11,824
Net income
-28,607
-29,068
-31,060
-14,468
-11,824
Net income available to common shareholders
-28,607
-29,068
-31,060
-14,468
-11,824
Basic EPS
-1.47
-1.56
-1.69
-0.81
-0.90
Diluted EPS
-1.47
-1.56
-1.69
-0.81
-0.90
Basic average shares
18,535
18,574
18,395
17,860
13,169
Diluted average shares
18,535
18,574
18,395
17,860
13,169